Contact US

NeoMed is now part of the Avanos family.

NeoMed Supports GEDSA’s U.S. ENFit® Connector Conversion Schedule

The Global Enteral Device Supplier Association (GEDSA) recently released an ENFit Connector Conversion Schedule, which estab­lishes a time­line for member manu­fac­turers to phase out the manu­fac­ture of legacy feeding devices and tran­si­tion adapters. GEDSA member manu­fac­turers have aligned to only produce ISO 80369-3 compliant devices with ENFit connec­tors according to the following time­lines:

NeoMed supports this patient safety initia­tive and encour­ages manu­fac­turers, health­care profes­sionals, hospital purchasing depart­ments and distrib­u­tors to use this schedule to coor­di­nate ENFit imple­men­ta­tion.

Click here for more ENFit Updates.

Estimated # of Feeds Delivered

3 1 , 9 1 4 , 6 0 3

Estimated # of Medication Doses Delivered

4 1 , 9 3 9 , 6 8 5

Counters updated monthly


Transitioning to the safer ENFit® enteral connector is crucial to the advancement of patient safety

June 16, 2020

Watch this video from GEDSA to learn why…


NeoMed Awarded US Patent for ENFit® Low Dose Tip Syringe

November 25, 2019

NeoMed, an enteral feeding and medica­tion delivery solu­tion leader, announced today it has received intel­lec­tual prop­erty protec­tion for its ENFit® Low Dose Tip Syringe…


Avanos Medical, Inc. Completes NeoMed Acquisition

August 19, 2019

On July 8, Avanos completed the acqui­si­tion of NeoMed, Inc. … Its port­folio of enteral feeding and delivery solu­tions for neonatal and pedi­atric patients strengthens Avanos' Digestive Health fran­chise…


NeoMed Unveils NeoConnect at Home OTC Reusable ENFit Syringe Line in the U.S.

May 30, 2019

NeoMed is excited to unveil NeoConnect® at Home™, a reusable port­folio of ENFit syringes that do not require a physician’s prescrip­tion…